[P1] A

[P1-064-A] A new PCV2 and Mycoplasma hyopneumoniae vaccine administered with needle-syringe or needle-free device demonstrates uncompromised efficacy against PCV2-d challenge

*István Kiss¹, Nimród Pálmai¹, Tamás Révész¹, Han Smits², Gwenaelle Dauphin², Roman Krejci², Philippe Mazerolles² (1. Ceva Phylaxia, Budapest (Hungary), 2. Ceva Santé Animale, Libourne (France))

Keywords:

PCV2,Mycoplasma,hyopneumoniae,bivalent,vaccine,Acushot